3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
23
Breast Neoplasms
22
Colorectal Neoplasms
14
Ovarian Neoplasms
12
Lung Neoplasms
10
Neoplasm Metastasis
9
Stomach Neoplasms
8
Neoplasms
8
Nasopharyngeal Carcinoma
8
Leukemia, Myeloid, Acute
7
Triple Negative Breast Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
6
Rectal Neoplasms
6
Fallopian Tube Neoplasms
6
Recurrence
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Esophageal Squamous Cell Carcinoma
5
Uterine Cervical Neoplasms
4
Prostatic Neoplasms
4
Lymphoma, Non-Hodgkin
4
Leukemia
4
Head and Neck Neoplasms
4
Esophageal Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Pancreatic Neoplasms
3
Neoplasms by Site
3
Lymphoma, Large B-Cell, Diffuse
3
Adenocarcinoma
3
Urinary Bladder Neoplasms
2
Multiple Myeloma
2
Interventions
Methotrexate
2
Dactinomycin
2
Vincristine
1
Vacuum Curettage
1
Paclitaxel
1
Moxifloxacin
1
Etoposide
1
Drug Therapy
1
Cyclophosphamide
1
Cisplatin
1
Carboplatin
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Gestational Trophoblastic Disease
×
Drug Therapy
×
Clear all
NCT04756713
2022-05-27
ReCure
Brigham and Women's Hospital
Phase 3
Unknown
150 enrolled